Philippe G. Steg-Gabriel
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Perspectives on the Future of Clinical Trials at Circulation.
Journal: Circulation
Published: August 24, 2026
Recurrent Venous Thromboembolism in Cancer: A Foreboding Event.
Journal: Circulation
Published: July 13, 2026
The Legacy of Early PCSK9 Inhibitors: Less Lipid, Less Metal.
Journal: European journal of preventive cardiology
Published: June 14, 2026
Zoī cohort, a prospective cohort with comprehensive phenotyping for preventive medicine in France, first 1000 participants: cohort profile.
Journal: BMJ open
Published: May 26, 2026
Sex Differences in Trajectories of LDL Cholesterol Control in Chronic Coronary Syndromes.
Journal: European journal of preventive cardiology
Published: May 14, 2026
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
Journal: Circulation
Published: March 30, 2026
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial.
Journal: JAMA cardiology
Published: February 25, 2026
Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease.
Journal: American heart journal
Published: February 13, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromes.
Journal: Nature reviews. Cardiology
Published: February 02, 2026
In silico prediction of the lipid-lowering efficacy of the oral PCSK9 inhibitor enlicitide using a mechanistic computational model.
Journal: Atherosclerosis
Published: January 21, 2026
Last Updated: 09/26/2026